Industry Leaders Fireside Chat: What’s Happened in the Last Year & Where is the Field Headed Next?

Time: 8:40 am
day: Conference Day 1 P1

Details:

• Examining the evolution of the autoimmune cell therapy field over the last year
• Discussing progress across autologous, allogeneic, NK and in vivo modalities to uncover development strategies
• Considering indication selection strategies and the potential for indication diversification beyond lupus
• Exploring the future of the field to effectively scale and commercialise safe, durable therapies

Speakers:

Fred Aslan Fred Aslan, M.D. brings two decades of leadership in the life sciences industry as an executive, investor, and entrepreneur. Most recently, he served as President Read more

Samik Basu

Jennifer Chow Jennifer Chow is a pioneer in cell therapy, having led the launch of over 10 oncology therapeutics, including key CAR T cell therapies like Ide-cel, Read more

Clinton Weber